Biotech & Life Sciences Reservations open Page created Oct 29, 2026

Biotech Sponsors with Active Phase 2 Trials

Industry sponsors — mostly biotech companies — running Phase 2 or Phase 1/2 trials that are recruiting, not yet recruiting or active on ClinicalTrials.gov, with investigational product, condition, phase, NCT number, trial status and countries.

Fields we plan to include

Lead sponsor
Investigational product
Condition
Phase
NCT number
Overall status
Therapeutic area
Trial countries
Start and primary completion dates
Number of active Phase 2 trials per sponsor

Data Preview

* Free sample rows, unverified and may contain errors. This list isn't for sale yet.
SponsorProductConditionPhase
Rivus Pharmaceuticals, Inc.SourceHU6MASHPhase 2 (NCT07491458)
Adverum Biotechnologies, Inc.SourceIxo-vecNeovascular age-related macular degenerationPhase 2 (NCT07630649)
SynthekineSourceSTK-012Advanced solid tumor / NSCLCPhase 1/2 (NCT05098132)
Kriya Therapeutics, Inc.SourceVV-14303MASHPhase 1/2 (NCT07732400)
TORL Biotherapeutics, LLCSourceTORL-1-23Epithelial ovarian cancerPhase 2 (NCT06690775)

Estimated ~2,000 entries. If people reserve it, we'll try to compile it (we can't compile every list).

* No charge now. Purchase is optional.

Why Phase 2 sponsors are the most active buyers of clinical services

Phase 2 is where a drug candidate moves from safety in small cohorts to its first real test of efficacy and dose. For a biotech company it is usually the most expensive stage it runs on its own before partnering or pivotal trials, and it is when it buys the most outside help: CROs, clinical sites, central labs, imaging core labs, eCOA and EDC vendors, patient-recruitment firms, drug supply and packaging, and regulatory consultants.

What ClinicalTrials.gov tells you

FieldWhy it matters
Lead sponsor and sponsor classSeparates industry sponsors from academic, NIH and other sponsors
PhasePhase 2 and combined Phase 1/2 designs indicate proof-of-concept stage
Overall statusNot yet recruiting and recruiting trials are still procuring sites and services; active-not-recruiting trials are in follow-up
Conditions and interventionsTherapeutic area and modality — small molecule, antibody, ADC, gene therapy, cell therapy
LocationsCountries and sites, useful for regional CROs and site networks

A search of the registry for industry-sponsored Phase 2 trials that are recruiting, not yet recruiting or active returns more than 5,000 studies. Many sponsors run several trials, so the number of distinct companies is lower; large pharma, Chinese biotechs and small US and European venture-backed companies all appear.

Signals worth watching

  • Not yet recruiting trials have often not chosen all sites or vendors.
  • Combined Phase 1/2 designs in oncology and gene therapy can expand quickly into dose-expansion cohorts.
  • Crowded indications such as MASH, obesity and NSCLC create competition for sites and patients.

Registration is required for most interventional drug trials under FDAAA 801, so the registry is broad, but sponsor names are entered as free text and need normalising across subsidiaries.

Frequently Asked Questions

Q.What is the goal of a Phase 2 trial?

Phase 2 trials test whether a drug works in patients with the target condition and help select the dose and endpoints for pivotal Phase 3 trials, while continuing to collect safety data.

Q.What is a Phase 1/2 trial?

It is a combined design that starts with dose escalation for safety and moves into expansion cohorts that look for efficacy signals, common in oncology and gene therapy.

Q.Which trials must be registered on ClinicalTrials.gov?

Under FDAAA 801, most controlled interventional trials of FDA-regulated drugs, biologics and devices, other than Phase 1 drug trials, must be registered and report results.

Q.What is the difference between recruiting and active, not recruiting?

Recruiting trials are enrolling participants; active, not recruiting trials have finished enrolment and are treating or following participants.

Q.Can I buy the list now?

Not yet. Sample rows are free. We try to compile lists that people reserve (we can't compile every list). If we do, we'll email everyone who reserved it a purchase link (buying is optional). If we don't, nothing happens and you're never charged.

Q.What does it cost?

Sample rows are free. A list is $49, paid only if we compile it and you decide to buy. There is no free trial or subscription.